Haemonetics Corporation CEO to Engage with Investors at the Upcoming Raymond James Conference Chris Simon, the CEO of Haemonetics Corporation, is set to participate in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026, discussing key insights with investors.

Haemonetics Corporation CEO to Engage with Investors at the Upcoming Raymond James Conference #United_States #Boston #Haemonetics #Investors_Conference #Chris_Simon